Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Sign Up
Cited by 448

The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.

Neutrophil–lymphocyte ratio reflects hepatocellular carcinoma recurrence after liver transplantation via inflammatory microenvironment

Motomura, Takashi, Shirabe, Ken, Mano, Yohei, Muto, Jun, Toshima, Takeo, Umemoto, Yuichiro, Fukuhara, Takasuke, Uchiyama, Hideaki, Ikegami, Toru, Yoshizumi, Tomoharu, Soejima, Yuji, Maehara, Yoshihiko·2013·Journal of Hepatology
DOI 10.1016/j.jhep.2012.08.017
Open this paper in CoChat — free account

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.jhep.2012.08.017

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 2 references

Research works printed but not linked: 28

  1. Mazzaferro, 1996, Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis, N Engl J Med, 334, 693, 10.1056/NEJM199603143341104 · DOI · Paper page
  2. Yao, 2001, Liver transplantation for hepatocellular carcinoma: expansion of the tumor size limits does not adversely impact survival, Hepatology, 33, 1394, 10.1053/jhep.2001.24563 · DOI · Paper page
  3. Mazzaferro, 2009, Predicting survival after liver transplantation in patients with hepatocellular carcinoma beyond the Milan criteria: a retrospective, exploratory analysis, Lancet Oncol, 10, 35, 10.1016/S1470-2045(08)70284-5 · DOI · Paper page
  4. Taketomi, 2009, Impact of des-gamma-carboxy prothrombin and tumor size on the recurrence of hepatocellular carcinoma after living donor liver transplantation, Transplantation, 87, 531, 10.1097/TP.0b013e3181943bee · DOI · Paper page
  5. Balkwill, 2001, Inflammation and cancer: back to Virchow?, Lancet, 357, 539, 10.1016/S0140-6736(00)04046-0 · DOI · Paper page
  6. Jaiswal, 2000, Inflammatory cytokines induce DNA damage and inhibit DNA repair in cholangiocarcinoma cells by a nitric oxide-dependent mechanism, Cancer Res, 60, 184
  7. Walsh, 2005, Neutrophil-lymphocyte ratio as a prognostic factor in colorectal cancer, J Surg Oncol, 91, 181, 10.1002/jso.20329 · DOI · Paper page
  8. Gomez, 2008, Preoperative neutrophil-to-lymphocyte ratio as a prognostic predictor after curative resection for hepatocellular carcinoma, World J Surg, 32, 1757, 10.1007/s00268-008-9552-6 · DOI · Paper page
  9. Gomez, 2008, Impact of systemic inflammation on outcome following resection for intrahepatic cholangiocarcinoma, J Surg Oncol, 97, 513, 10.1002/jso.21001 · DOI
  10. Bhatti, 2010, Preoperative hematologic markers as independent predictors of prognosis in resected pancreatic ductal adenocarcinoma: neutrophil-lymphocyte versus platelet-lymphocyte ratio, Am J Surg, 200, 197, 10.1016/j.amjsurg.2009.08.041 · DOI · Paper page
  11. Halazun, 2009, Negative impact of neutrophil-lymphocyte ratio on outcome after liver transplantation for hepatocellular carcinoma, Ann Surg, 250, 141, 10.1097/SLA.0b013e3181a77e59 · DOI · Paper page
  12. Lo, 2004, The role and limitation of living donor liver transplantation for hepatocellular carcinoma, Liver Transpl, 10, 440, 10.1002/lt.20097 · doi:10.1002/lt.20097
  13. Soejima, 2007, Extended indication for living donor liver transplantation in patients with hepatocellular carcinoma, Transplantation, 83, 893, 10.1097/01.tp.0000259015.46798.ec · doi:10.1097/01.tp.0000259015.46798.ec
  14. Pollard, 2004, Tumour-educated macrophages promote tumour progression and metastasis, Nat Rev Cancer, 4, 71, 10.1038/nrc1256 · DOI · Paper page
  15. Cortez-Retamozo, 2012, Origins of tumor-associated macrophages and neutrophils, Proc Natl Acad Sci U S A, 109, 2491, 10.1073/pnas.1113744109 · DOI · Paper page
  16. Bertuzzo, 2011, Analysis of factors affecting recurrence of hepatocellular carcinoma after liver transplantation with a special focus on inflammation markers, Transplantation, 91, 1279, 10.1097/TP.0b013e3182187cf0 · DOI
  17. Waugh, 2008, The interleukin-8 pathway in cancer, Clin Cancer Res, 14, 6735, 10.1158/1078-0432.CCR-07-4843 · DOI · Paper page
  18. Kuang, 2010, Tumor-activated monocytes promote expansion of IL-17-producing CD8+ T cells in hepatocellular carcinoma patients, J Immunol, 185, 1544, 10.4049/jimmunol.0904094 · DOI
  19. Kuang, 2011, Peritumoral neutrophils link inflammatory response to disease progression by fostering angiogenesis in hepatocellular carcinoma, J Hepatol, 54, 948, 10.1016/j.jhep.2010.08.041 · DOI · Paper page
  20. Kono, 2011, Role of IL-17A in neutrophil recruitment and hepatic injury after warm ischemia-reperfusion mice, J Immunol, 187, 4818, 10.4049/jimmunol.1100490 · DOI
  21. Kuang, 2010, Activated monocytes in peritumoral stroma of hepatocellular carcinoma promote expansion of memory T helper 17 cells, Hepatology, 51, 154, 10.1002/hep.23291 · DOI · Paper page
  22. Daurkin, 2011, Tumor-associated macrophages mediate immunosuppression in the renal cancer microenvironment by activating the 15-lipoxygenase-2 pathway, Cancer Res, 71, 6400, 10.1158/0008-5472.CAN-11-1261 · DOI · Paper page
  23. Tosolini, 2011, Clinical impact of different classes of infiltrating T cytotoxic and helper cells (Th1, Th2, Treg, Th17) in patients with colorectal cancer, Cancer Res, 71, 1263, 10.1158/0008-5472.CAN-10-2907 · DOI · Paper page
  24. Hasita, 2010, Significance of alternatively activated macrophages in patients with intrahepatic cholangiocarcinoma, Cancer Sci, 101, 1913, 10.1111/j.1349-7006.2010.01614.x · DOI · Paper page
  25. Li, 2011, Interleukin 17A promotes hepatocellular carcinoma metastasis via NF-kB induced matrix metalloproteinases 2 and 9 expression, PLoS ONE, 6, e21816, 10.1371/journal.pone.0021816 · DOI · Paper page
  26. Zhao, 2011, Interleukin-17-educated monocytes suppress cytotoxic T-cell function through B7–H1 in hepatocellular carcinoma patients, Eur J Immunol, 41, 2314, 10.1002/eji.201041282 · DOI
  27. Kuang, 2009, Activated monocytes in peritumoral stroma of hepatocellular carcinoma foster immune privilege and disease progression through PD-L1, J Exp Med, 206, 1327, 10.1084/jem.20082173 · DOI · Paper page
  28. Radosavljevic, 2010, Interleukin-17 may be a valuable serum tumor marker in patients with colorectal carcinoma, Neoplasma, 57, 135, 10.4149/neo_2010_02_135 · doi:10.4149/neo_2010_02_135

Cited by

See all 448

Metadata

Authors
Motomura, T., Shirabe, K., Mano, Y., Muto, J., Toshima, T., Umemoto, Y., Fukuhara, T., Uchiyama, H., Ikegami, T., Yoshizumi, T., Soejima, Y., & Maehara, Y.
Venue
Journal of Hepatology
Publisher
Elsevier BV
Published
2013-01
Volume
58
Issue
1
Pages
58-64
ISSN
0168-8278 (ISSN-L)
DOI
10.1016/j.jhep.2012.08.017
OpenAlex
W1970902949
Cited by
448
References
2
FWCI
12.07
Type
journal article
Language
en
Open access
closed
Licence
www.elsevier.com/tdm/userlicense/1.0/ (tdm)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Neutrophil–lymphocyte ratio reflects hepatocellular carcinoma recurrence after liver transplantation via inflammatory microenvironment. https://app.cochat.ai/papers/10.1016/j.jhep.2012.08.017
The paper
Motomura, T., Shirabe, K., Mano, Y., Muto, J., Toshima, T., Umemoto, Y., Fukuhara, T., Uchiyama, H., Ikegami, T., Yoshizumi, T., Soejima, Y., & Maehara, Y. (2013). Neutrophil–lymphocyte ratio reflects hepatocellular carcinoma recurrence after liver transplantation via inflammatory microenvironment. Journal of Hepatology. https://doi.org/10.1016/j.jhep.2012.08.017

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.